FWP
ATRS

Firethorn Wealth Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Firethorn Wealth Partners’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,000
Closed -$7K – 164
2021
Q4 		$7K Buy
+2,000
New +$7K 0.01% 144

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Firethorn Wealth Partners's ATRS Position: Q2 2022 in Review

Firethorn Wealth Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 84,069 shares — an estimated $345K sold.

Firethorn Wealth Partners first reported a position in ATRS in Q4 2020 and held it in 5 quarters. The position peaked at $345K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Firethorn Wealth Partners reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Firethorn Wealth Partners sold 84,069 Antares Pharma, Inc. shares in Q2 2022, an estimated $345K.
  • Firethorn Wealth Partners first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 5 quarters.
  • Firethorn Wealth Partners's Antares Pharma, Inc. position peaked at $345K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Firethorn Wealth Partners's 13F filing for Q2 2022, filed 3 Aug 2022.